Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Atherosclerosis

• Publication date

  1999-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0021-9150(99)00034-9PMID 10381281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3.P.127 Inhibition of LDL-associated phospholipase A2: A novel anti-atherosclerotic approach

  1997cited by this paper
• Antibody Catalysis of BAc2 Aryl Carbamate Ester Hydrolysis: A Highly Disfavored Chemical Process

  1997cited by this paper
• The growing phospholipase A2 superfamily of signal transduction enzymes.

  1997cited by this paper
• Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin‐ceramide pathway in human macrophages

  1997cited by this paper
• Mammalian platelet-activating factor acetylhydrolases.

  1996cited by this paper
• Degradation of pyrene-labelled phospholipids by lysosomal phospholipases in vitro. Dependence of degradation on the length and position of the labelled and unlabelled acyl chains.

  1996cited by this paper
• The Energetics of Hydrogen Bonds in Model Systems: Implications for Enzymatic Catalysis

  1996cited by this paper
• Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins.

  1996cited by this paper
• Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U‐937 macrophage‐like cells

  1996cited by this paper
• Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase.

  1996cited by this paper
• Enhanced Association of Platelet-activating Factor Acetylhydrolase with Lipoprotein (a) in Comparison with Low Density Lipoprotein (*)

  1995cited by this paper
• Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

  1995cited by this paper
• Mammalian calcium-independent phospholipase A2.

  1995cited by this paper
• Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad (*)

  1995cited by this paper
• Metabolism and distribution of intramolecular excimer-forming dipyrenebutanoyl glycerophospholipids in human fibroblasts. Marked resistance to metabolic degradation.

  1995cited by this paper
• Synthesis of [32P]labelled 1-O-alkyl-2-desoxy-2-amino-sn′-glycero-3-phosphocholines

  1994cited by this paper
• The plasma PAF acetylhydrolase prevents oxidative modification of low density lipoprotein

  1994cited by this paper
• The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties.

  1993cited by this paper
• The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein.

  1992cited by this paper
• Defining the dimensions of the catalytic site of phospholipase A2 using amide substrate analogs

  1992cited by this paper
• Rapid synthesis of 2-desoxy-2-amino-3-phosphocholine-glycerinic-acid- alkylester, 1-alkyl-1-desoxy- and 1-O-alkyl-2-desoxy-2-amino-sn-glycero-3- phosphocholines, -3-phospho-N,N'-dimethylethanolamine and -3-phospho-Fmoc- serine-methylester.

  1992cited by this paper
• Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases.

  1991cited by this paper
• PAF receptor structure: A hypothesis

  1991cited by this paper
• Platelet-activating factor acetylhydrolase activity in human tissues and blood cells

  1991cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.

  1991cited by this paper
• Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.

  1991cited by this paper
• Interfacial catalysis: the mechanism of phospholipase A2

  1990cited by this paper
• An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.

  1989cited by this paper
• Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

  1989cited by this paper
• New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy

  1988cited by this paper
• Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity.

  1987cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Purification and properties.

  1987cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

  1987cited by this paper
• Platelet-Activating Factor and Related Lipid Mediators

  1987cited by this paper
• Evidence for hemiketals as intermediates in the inactivation of serine proteinases with halomethyl ketones.

  1986cited by this paper
• Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor.

  1983cited by this paper
• Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats.

  1983cited by this paper
• A new method for the stereospecific synthesis of ether phospholipids. Preparation of the amide analog of platelet-activating factor and related derivatives

  1982cited by this paper
• Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues.

  1981cited by this paper
• A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

  1981cited by this paper
• Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)

  1976cited by this paper
• Establishment of a carbanion mechanism for ester hydrolysis and the unimportance of electrostatic effects of .alpha. substituents on the rates of hydroxide ion attack at the ester carbonyl group

  1968cited by this paper
• The Mechanism of the Alkaline Hydrolysis of p-Nitrophenyl N-Methylcarbamate1

  1965cited by this paper
• Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

  1962cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Lipid Metabolism-Driven CNS Repair via Targeted EV Delivery of PAF to Neurons.

  2026cites this paper
• Phospholipase A Subclasses in Acute Respiratory Distress Syndrome

  2019cites this paper
• Quantitative Translational Analysis of Brain Kynurenic Acid Modulation via Irreversible Kynurenine Aminotransferase II Inhibition

  2018cites this paper
• Phospholipase A2 subclasses in acute respiratory distress syndrome.

  2009cites this paper
• Activity-based proteomics: enzymatic activity profiling in complex proteomes

  2006cites this paper
• Synthesis and activity of C11-modified wortmannin probes for PI3 kinase.

  2005cites this paper
• Functional profiling of the proteome with affinity labels.

  2003cites this paper
• Synthesis and Activity of C 11-Modified Wortmannin Probes for PI 3 Kinase

  year unknowncites this paper